XML 95 R83.htm IDEA: XBRL DOCUMENT v3.22.1
Parent Company only Financial Information - Condensed Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Condensed Financial Statements, Captions [Line Items]                    
Net income $ 3,181 $ 3,216 $ 4,162 $ 2,809 $ 1,785 $ 495 $ 1,550 $ 473 $ 13,368 $ 4,303
Adjustments to reconcile net income to net cash provided by operating activities:                    
Net cash provided by operating activities                 16,209 14,753
Cash flow from investing activities:                    
Net cash used for investing activities                 (59,013) (453,838)
Cash flow from financing activities:                    
Proceeds from issuance of subordinated debt, net                 29,224 20,000
Proceeds from exercised stock options                 243 247
Net cash provided by financing activities                 94,743 743,260
(Decrease) Increase in cash and cash equivalents                 51,939 304,175
Cash and cash equivalents, beginning of period       418,517       114,342 418,517 114,342
Cash and cash equivalents, end of period 470,456       418,517       470,456 418,517
Parent Company [Member]                    
Condensed Financial Statements, Captions [Line Items]                    
Net income                 13,368 4,303
Adjustments to reconcile net income to net cash provided by operating activities:                    
Equity in undistributed (earnings) of subsidiary income                 (14,792) (5,452)
Change in other assets and other liabilities, net                 (4,157) (630)
Net cash provided by operating activities                 (5,581) (1,779)
Cash flow from investing activities:                    
Investment in subsidiary                 (30,000) (10,000)
Net cash used for investing activities                 (30,000) (10,000)
Cash flow from financing activities:                    
Proceeds from issuance of subordinated debt, net                 34,224 20,000
Proceeds from exercised stock options                 243 247
Net cash provided by financing activities                 34,467 20,247
(Decrease) Increase in cash and cash equivalents                 (1,114) 8,468
Cash and cash equivalents, beginning of period       $ 11,082       $ 2,614 11,082 2,614
Cash and cash equivalents, end of period $ 9,968       $ 11,082       $ 9,968 $ 11,082